-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Epilepsy is a life-altering disorder defined by a predisposition to unprovoked seizures, but the important physiological and neuropsychiatric manifestations of epilepsy are outside the scope of this definition
Epilepsy is a life-altering disorder defined by a predisposition to unprovoked seizures, but the important physiological and neuropsychiatric manifestations of epilepsy are outside the scope of this definition
A better understanding of the factors that influence quality of life with PTE is essential to facilitate efforts to identify individuals at greatest risk for poor quality of life, and to identify effective interventions to mitigate/prevent adverse health conditions and/or quality of life
Quality of life is a complex concept that involves a person's assessment of their life within their value system and cultural context, and is influenced by personal standards, expectations, goals, and concerns
This observational cohort study from the Veterans Health Administration included veterans with epilepsy after the events of 9/11
This observational cohort study from the Veterans Health Administration included veterans with epilepsy after the events of 9/11
- A total of 529 patients with epilepsy were included in the analysis: 249 controls (ie, patients with epilepsy without DRE or PTE), 124 patients with DRE, 86 patients with PTE, and 70 patients with PT-DRE
In PTE patients, the prevalence of DRE was significantly higher than in nontraumatic epilepsy patients
Source: Gugger JJ, Kennedy E, Panahi S, et al.
Multimodal Quality of Life Assessment in Post-9/11 Veterans With Epilepsy: Impact of Drug Resistance, Traumatic Brain Injury, and Comorbidity [published online ahead of print, 2022 Apr 6].
Neurology.
2022;10.
1212/WNL.
0000000000200146.
doi:10.
1212/WNL.
0000000000200146 Gugger JJ, Kennedy E, Panahi S, et al.
Multimodal Quality of Life Assessment in Post-9/11 Veterans With Epilepsy: Impact of Drug Resistance, Traumatic Brain Injury, and Comorbidity [published online ahead of print, 2022 Apr 6].
Neurology.
2022;10.
1212/WNL.
0000000000200146.
doi:10.
1212/WNL.
0000000000200146Gugger JJ, Kennedy E, Panahi S, et al.
Multimodal Quality of Life Assessment in Post-9/11 Veterans With Epilepsy: Impact of Drug Resistance, Traumatic Brain Injury, and Comorbidity [published online ahead of print, 2022 Apr 6].
Neurology.
2022;10.
1212/WNL.
0000000000200146.
doi:10.
1212/WNL.
0000000000200146Leave
a message here
